Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS10009794HBVENSG00000114200.10protein_codingBCHENoNo590P06276
TVIS10036366HBVENSG00000114200.10protein_codingBCHENoNo590P06276
TVIS30058841HIVENSG00000114200.10protein_codingBCHENoNo590P06276
TVIS30058842HIVENSG00000114200.10protein_codingBCHENoNo590P06276
TVIS30058843HIVENSG00000114200.10protein_codingBCHENoNo590P06276
TVIS30058844HIVENSG00000114200.10protein_codingBCHENoNo590P06276
TVIS30058845HIVENSG00000114200.10protein_codingBCHENoNo590P06276
TVIS30058846HIVENSG00000114200.10protein_codingBCHENoNo590P06276
TVIS30058847HIVENSG00000114200.10protein_codingBCHENoNo590P06276
TVIS30058848HIVENSG00000114200.10protein_codingBCHENoNo590P06276
TCGA Plot Options
Drug Information
GeneBCHE
DrugBank IDDB01010
Drug NameEdrophonium
Target IDBE0002180
UniProt IDP06276
Regulation Typeinhibitor
PubMed IDs1438284; 9398183
CitationsHarel M, Sussman JL, Krejci E, Bon S, Chanal P, Massoulie J, Silman I: Conversion of acetylcholinesterase to butyrylcholinesterase: modeling and mutagenesis. Proc Natl Acad Sci U S A. 1992 Nov 15;89(22):10827-31.@@Saxena A, Redman AM, Jiang X, Lockridge O, Doctor BP: Differences in active site gorge dimensions of cholinesterases revealed by binding of inhibitors to human butyrylcholinesterase. Biochemistry. 1997 Dec 2;36(48):14642-51.
GroupsApproved
Direct ClassificationAniline and substituted anilines
SMILESCC[N+](C)(C)C1=CC(O)=CC=C1
Pathways
PharmGKBPA449437
ChEMBLCHEMBL1104